Ares Acquisition Corporation II
AACT
$11.18
$0.0050.05%
| Weiss Ratings | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | C- | |||
| Rating Factors | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.68% | |||
| 30-Day Total Return | 1.41% | |||
| 60-Day Total Return | 2.05% | |||
| 90-Day Total Return | 2.81% | |||
| Year to Date Total Return | 1.87% | |||
| 1-Year Total Return | 5.72% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -0.27% | |||
| 52-Week Low % Change | 5.88% | |||
| Price | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.20 | |||
| 52-Week Low Price | $10.55 | |||
| 52-Week Low Price (Date) | Mar 19, 2024 | |||
| 52-Week High Price (Date) | Mar 14, 2025 | |||
| Valuation | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 698.13M | |||
| Enterprise Value | 702.15M | |||
| Price/Earnings (TTM) | 26.86 | |||
| Earnings Per Share (TTM) | 0.42 | |||
| Earnings Per Share Growth | 45.59% | |||
| Price/Earnings To Growth | 0.59 | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -31.68 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $11.18 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -395.47 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 62.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 750 7300 | |||
| Address | 245 Park Avenue New York, NY 10167 | |||
| Website | www.aresacquisitioncorporationii.com | |||
| Country | United States | |||
| Year Founded | 2021 | |||
| Profitability | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.21% | |||
| Return on Equity | -- | |||
| Income Statement | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.78M | |||
| Net Income (TTM) | 25.99M | |||
| Net Income Avl. to Common (TTM) | 25.99M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -13.05% | |||
| EPS Diluted (TTM) | 0.42 | |||
| EPS Diluted Growth (Q YOY) | -12.80% | |||
| Balance Sheet | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 975.30K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 1.10M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -22.04M | |||
| Current Ratio (Q) | 1.487 | |||
| Book Value Per Share (Q) | -$0.35 | |||
| Total Assets (Q) | 551.90M | |||
| Total Current Liabilities (Q) | 740.60K | |||
| Total Debt (Q) | 5.00M | |||
| Total Liabilities (Q) | 573.94M | |||
| Total Common Equity (Q) | -22.04M | |||
| Cash Flow | AACT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -929.90K | |||
| Levered Free Cash Flow (TTM) | -264.00K | |||
| Cash from Operations (TTM) | -929.90K | |||
